Oroxylin A

Oroxylin A is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 747 references associated with Oroxylin A in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Oroxylin A

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Oroxylin A

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Seizures D012640 87 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Per page 10 20 | Total 12

NCBI Entrez Crosslinks

All references with Oroxylin A

Download all related citations
Per page 10 20 50 100 | Total 124
Authors Title Published Journal PubMed Link
pmid:
Chen Y et al. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. 2000 Biochem. Pharmacol. pmid:10751555
Ma SC et al. Antiviral Chinese medicinal herbs against respiratory syncytial virus. 2002 J Ethnopharmacol pmid:11801383
Huen MS et al. 5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. 2003 Biochem. Pharmacol. pmid:12818372
Li HB and Chen F Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. 2005 J Chromatogr A pmid:15941045
Suresh Babu K et al. Synthesis and in vitro study of novel 7-O-acyl derivatives of Oroxylin A as antibacterial agents. 2005 Bioorg. Med. Chem. Lett. pmid:16046127
Pomilio AB et al. Antimicrobial constituents of Gomphrena martiana and Gomphrena boliviana. 1992 J Ethnopharmacol pmid:1608273
Kim YH et al. Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and wogonin in rat plasma. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16893689
Huang WH et al. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. 2006 Biosci. Biotechnol. Biochem. pmid:17031041
Hu Y et al. Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. 2006 Biochem. Biophys. Res. Commun. pmid:17069758
Kim DH et al. Effect of the flavonoid, oroxylin A, on transient cerebral hypoperfusion-induced memory impairment in mice. 2006 Pharmacol. Biochem. Behav. pmid:17174385
Kim DH et al. The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice. 2007 Neurobiol Learn Mem pmid:17196405
Kim YH et al. Pharmacokinetics of baicalein, baicalin and wogonin after oral administration of a standardized extract of Scutellaria baicalensis, PF-2405 in rats. 2007 Arch. Pharm. Res. pmid:17366750
Chen JJ et al. New dihydrochalcones and anti-platelet aggregation constituents from the leaves of Muntingia calabura. 2007 Planta Med. pmid:17516329
Hattori T et al. Saireito probably prevents mesangial cell proliferation in HIGA mice via PDGF-BB tyrosine kinase inhibition. 2007 Clin. Exp. Nephrol. pmid:18085387
Hari Babu T et al. Synthesis and biological evaluation of novel 8-aminomethylated oroxylin A analogues as alpha-glucosidase inhibitors. 2008 Bioorg. Med. Chem. Lett. pmid:18255289
Kim DH et al. The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice. 2008 Neuropharmacology pmid:18620712
Yang Y et al. Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells. 2008 J. Pharm. Pharmacol. pmid:18957166
Sun Y et al. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. 2009 Eur. J. Pharmacol. pmid:19100732
Li HN et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. 2009 Toxicology pmid:19135124
Shih HC et al. In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root. 2009 J. Biomed. Sci. pmid:19272127
Liu W et al. MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells. 2009 Cancer Lett. pmid:19473757
Li J et al. Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora. 2009 J. Nat. Prod. pmid:19555121
Zhao L et al. Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. 2010 Cancer Chemother. Pharmacol. pmid:19585117
Mu R et al. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells. 2009 Mol. Carcinog. pmid:19626645
Go WJ et al. Evaluation of the flavonoid oroxylin A as an inhibitor of P-glycoprotein-mediated cellular efflux. 2009 J. Nat. Prod. pmid:19739602
Zhou XQ et al. [Flavonoids from Scutellaria baicalensis and their bioactivities]. 2009 Beijing Da Xue Xue Bao pmid:19829679
Gao Y et al. Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation. 2010 J. Cancer Res. Clin. Oncol. pmid:19888602
Marques MR et al. Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers. 2010 Fitoterapia pmid:20117183
Zhou Q et al. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes. 2010 Pharm. Res. pmid:20411407
Trinh HT et al. Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice. 2010 Acta Pharmacol. Sin. pmid:20453872
Lee S et al. Oroxylin A, a flavonoid, stimulates adult neurogenesis in the hippocampal dentate gyrus region of mice. 2010 Neurochem. Res. pmid:20680459
SASTRI VD and SESHADRI TR Constitution of oroxylin-A. 1946 Curr. Sci. pmid:20999086
Li C et al. Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product. 2011 J Pharm Biomed Anal pmid:21051171
Kumar GS et al. Synthesis and biological evaluation of novel benzyl-substituted flavones as free radical (DPPH) scavengers and α-glucosidase inhibitors. 2010 J Asian Nat Prod Res pmid:21061220
Jeon SJ et al. Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. 2011 Neurosci. Res. pmid:21145362
Yang HY et al. Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway. 2012 Mol. Carcinog. pmid:21557331
Kim DH et al. 4'-bromo-5,6,7-trimethoxyflavone represses lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-κB signaling pathway in RAW 264.7 macrophages. 2012 Bioorg. Med. Chem. Lett. pmid:22101131
Lu QY et al. Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts. 2012 Pancreas pmid:22158070
Li C et al. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae. 2012 AAPS J pmid:22167378
Fu W et al. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives. 2012 Bioorg. Med. Chem. Lett. pmid:22196122
Lu Z et al. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. 2012 Toxicol. Lett. pmid:22245252
Zhu B et al. Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway. 2012 Toxicol. Appl. Pharmacol. pmid:22310179
Pham TA et al. Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production. 2012 Bioorg. Med. Chem. Lett. pmid:22366656
Hu R et al. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors. 2012 Anticancer Drugs pmid:22526619
Zou M et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. 2012 Cell. Signal. pmid:22560876
Ha J et al. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. 2012 Biochem. Cell Biol. pmid:22607196
Xu M et al. Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. 2012 Toxicol. Lett. pmid:22609744
Tong L et al. Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry. 2012 J Pharm Biomed Anal pmid:22703838
Wang H et al. [Vasodilator effect of oroxylin A on thoracic aorta isolated from rats]. 2012 Zhong Xi Yi Jie He Xue Bao pmid:22883404
Yao J et al. Oroxylin A prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-κB signaling. 2014 Mol. Carcinog. pmid:22949302
Tseng TL et al. Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents. 2012 PLoS ONE pmid:23071799
Guo H et al. [Preparation of flavonoid reference standards from Scutellariae Radix under the guidance of high performance liquid chromatography-mass spectrometry analysis]. 2012 Se Pu pmid:23189664
Liu PW et al. STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells. 2012 PLoS ONE pmid:23236370
Song X et al. Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide. 2012 Pharmacol Rep pmid:23238475
Dong J et al. Oroxylin A inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. 2013 PLoS Comput. Biol. pmid:23349625
Yoon SY et al. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro. 2013 Arch. Pharm. Res. pmid:23371806
Zhu L et al. Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. 2013 Toxicol. Lett. pmid:23470866
Wei L et al. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II. 2013 Biochim. Biophys. Acta pmid:23500080
Liu X et al. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. 2013 Arch. Pharm. Res. pmid:23543630
Wei L et al. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. 2013 Cell Death Dis pmid:23598413
Dai Q et al. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. 2013 Int. J. Biochem. Cell Biol. pmid:23612020
dela Peña IC et al. 5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats. 2013 Eur. J. Pharmacol. pmid:23707903
Yang X et al. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway. 2013 Inflamm. Bowel Dis. pmid:23823704
Wang H et al. An estrogen receptor dependent mechanism of Oroxylin A in the repression of inflammatory response. 2013 PLoS ONE pmid:23922737
Hui H et al. Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα. 2014 Int. J. Cancer pmid:23934681
Zhu R et al. Oroxylin A accelerates liver regeneration in CClâ‚„-induced acute liver injury mice. 2013 PLoS ONE pmid:23951204
Ku SK et al. Antithrombotic activities of oroxylin A in vitro and in vivo. 2014 Arch. Pharm. Res. pmid:23963976
Li C et al. Influence of mefenamic acid on the intestinal absorption and metabolism of three bioactive flavones in Radix Scutellariae and potential pharmacological impact. 2014 Pharm Biol pmid:24102566
Fong SY and Zuo Z Species difference in the inhibitory potentials of non-steroidal anti-inflammatory drugs on the hepatic sulfation and glucuronidation of bioactive flavonoids: differential observations among common inhibition parameters. 2014 Xenobiotica pmid:24168065
Ku SK et al. Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. 2014 BMB Rep pmid:24286327
Qiu J et al. Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin. 2013 PLoS ONE pmid:24312202
Cheng Y et al. Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway. 2014 Anticancer Drugs pmid:24637576
Li X et al. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway. 2015 Arch. Toxicol. pmid:24671465
Fong SY et al. Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, wogonin, oroxylin A and their glucuronides baicalin, wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies. 2014 J Pharm Biomed Anal pmid:24803030
Wang Y et al. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. 2014 Biochem. Pharmacol. pmid:24858801
Hui H et al. Oroxylin A inhibits ATRA-induced IL-6 expression involved in retinoic acid syndrome by down-regulating CHOP. 2014 Gene pmid:25192658
Zou M et al. Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway. 2015 Mol. Carcinog. pmid:25213258
Kim DH et al. Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice. 2014 Brain Res. Bull. pmid:25218897
Ye M et al. Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation. 2014 Biochem. Cell Biol. pmid:25247252
Qiao C et al. UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells. 2015 J. Cell. Physiol. pmid:25251374
Singh J and Kakkar P Oroxylin A, a constituent of Oroxylum indicum inhibits adipogenesis and induces apoptosis in 3T3-L1 cells. 2014 Phytomedicine pmid:25442284
Huang H et al. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice. 2015 J. Surg. Res. pmid:25818981
Wei L et al. Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization. 2015 Cell Death Dis pmid:25855962
Zhao K et al. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. 2015 J Hematol Oncol pmid:25902914
Dai Q et al. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells. 2016 Mol. Carcinog. pmid:26259145
Tseng TL et al. Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock. 2016 Br. J. Pharmacol. pmid:26694894
Wei L et al. Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells. 2016 Mol. Carcinog. pmid:26741501
Zhou DG et al. Oroxylin A Inhibits Allergic Airway Inflammation in Ovalbumin (OVA)-Induced Asthma Murine Model. 2016 Inflammation pmid:26895180
Yang H et al. Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A. 2016 Sci Rep pmid:26905263
Qiao C et al. Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53. 2016 Oncotarget pmid:26958937
Hui H et al. Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells. 2016 J. Cancer Res. Clin. Oncol. pmid:27085528
Huang L et al. Application of a new method, orthogonal projection to latent structure (OPLS) combined with principal component analysis (PCA), to screening of prostaglandin E2 production inhibitory flavonoids in Scutellaria Root. 2016 J Nat Med pmid:27164908
Kwon BE et al. Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice. 2016 PLoS ONE pmid:27195463
Zhang YY et al. Enzymatic production of oroxylin A and hispidulin using a liverwort flavone 6-O-methyltransferase. 2016 FEBS Lett. pmid:27432544
Mangal P et al. Screening of six Ayurvedic medicinal plants for anti-obesity potential: An investigation on bioactive constituents from Oroxylum indicum (L.) Kurz bark. 2017 J Ethnopharmacol pmid:27469197
Li W et al. Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment. 2017 Mol. Carcinog. pmid:27533597
Lu L et al. Overview of Oroxylin A: A Promising Flavonoid Compound. 2016 Phytother Res pmid:27539056
Tan C et al. Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis. 2017 Pathol. Oncol. Res. pmid:27585443
Wang YL et al. Therapeutic potential of Oroxylin A in rheumatoid arthritis. 2016 Int. Immunopharmacol. pmid:27643663